(TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN)
Avicanna is a Canadian vertically-integrated biopharmaceutical company developing and commercializing various cannabinoid-based products for the global market place
WHY AVICANNA?
When we say vertically integrated, we mean it. Avicanna has 4 fully operating divisions to address the entire market for Cannabis products. As a Cannabis investor, why limit yourself to a Company with just one specialty, when Avicanna offers you exposure to the entire vertical.
CONSUMER RETAIL – COSMETICS
- The Only Known CBD Cosmetics Backed By Clinical Trials
- Full Line Of High End CBD Based Skin Care Products
- Already Commercializing In Colombia
- Global Distribution In H2 2020 In United States, Europe and Canada
- Canadian Distribution Through Shoppers Drug Mart
MEDICAL MARIJUANA
- Medical Cannabis 2.0 – Superior Products To Products Currently On The Market
- Evidence Backed Medical Cannabis So Doctors Can Prescribe With Confidence
- Launch Across Canada Immanent
- Exclusive Distribution Through Online Store Of Shoppers Drug Mart
- Global Distribution Through US, U.K, Australia, Colombia and Canada In H2 2020
PHARMACEUTICALS
- A Full Pipeline Of Pharmaceuticals In Various Stages Of Trials To Address Dermatology, Psychiatry, Neurology, Pain and Oncology
- 3 Products Already As Far As PHASE 2
CULTIVATION
- 500,000 Sq Ft Of Low Cost and USDA certified Organic Cannabis Cultivation In Colombia
- First Ever Export Of Feminized Hemp Seeds From Colombia (To United States). 7,000,000 Seeds For $380,000
- Additional 75,000,000 Seeds Available For Export In Several Pending Transactions
Click below to register
Tags: cannabinoids, CSE, Marijuana, Medical Cannabis by Shoppers, Rho Phyto, stocks, tsx